Evaluation of Topical Pomegranate Extracts in Management of Oral Lichen Planus (A Randomized Clinical Trial)
1 other identifier
interventional
42
1 country
2
Brief Summary
This study was conducted to estimate the hypothesis that the Pomegranate Extracts have no role in management of oral lichen planus
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Sep 2019
Shorter than P25 for phase_4
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2019
CompletedFirst Submitted
Initial submission to the registry
December 8, 2019
CompletedFirst Posted
Study publicly available on registry
December 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2019
CompletedFebruary 5, 2020
January 1, 2020
3 months
December 8, 2019
January 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual analog scale (VAS)
Pain assessment scale
4 weeks
Secondary Outcomes (2)
Sign score
4 weeks
OHIP-14 questionnaire
4 weeks
Study Arms (3)
Control group
ACTIVE COMPARATORTopical triamcinolone acetonide 0.1% available commercially (Kenacort- in orabase) has been used. Topical corticosteroid treatment has be repeated four times per day for four weeks.
Group S
EXPERIMENTALTopical pomegranate seeds extract treatment has been repeated four times per day for four weeks.
Group P
EXPERIMENTALTopical pomegranate peel extract treatment has been repeated four times per day for four weeks.
Interventions
Topical pomegranate seeds and peel extracts in the form of gel
Eligibility Criteria
You may not qualify if:
- Patients who excluded from the study were smokers, pregnant, lactating ladies and patients under topical and systemic steroids during the last two months. Uncontrolled diabetic patients or hypertension in addition to hepatic and cardiac patients were not included. In addition, any previous history of allergy to pomegranate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (2)
Oral Medicine and Periodontology Department
Cairo, Egypt
Faculty of Dentistry, Cairo University
Giza, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The clinical outcomes were assessed by an investigator masked about the treatment modality that has been used
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Oral Medicine and Periodontology, Cairo University, Egypt
Study Record Dates
First Submitted
December 8, 2019
First Posted
December 10, 2019
Study Start
September 1, 2019
Primary Completion
November 20, 2019
Study Completion
December 13, 2019
Last Updated
February 5, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share
Because the research not published yet.